164 related articles for article (PubMed ID: 34843122)
1. Expression of SET domain bifurcated histone lysine methyltransferase 1 and its clinical prognostic significance in hepatocellular carcinoma.
Wang C; Xia Z; Li Z; Ye F; Ji S; Lu C; Zhang H
J Clin Lab Anal; 2022 Jan; 36(1):e24090. PubMed ID: 34843122
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
Wong CM; Wei L; Law CT; Ho DW; Tsang FH; Au SL; Sze KM; Lee JM; Wong CC; Ng IO
Hepatology; 2016 Feb; 63(2):474-87. PubMed ID: 26481868
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of SMYD3 Is Predictive of Unfavorable Prognosis in Hepatocellular Carcinoma.
Fei X; Ma Y; Liu X; Meng Z
Tohoku J Exp Med; 2017 Nov; 243(3):219-226. PubMed ID: 29187705
[TBL] [Abstract][Full Text] [Related]
4. High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma.
He C; Xu J; Zhang J; Xie D; Ye H; Xiao Z; Cai M; Xu K; Zeng Y; Li H; Wang J
Hum Pathol; 2012 Sep; 43(9):1425-35. PubMed ID: 22406368
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
6. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma.
Chen Y; Yang S; Hu J; Yu C; He M; Cai Z
PLoS One; 2016; 11(5):e0154939. PubMed ID: 27183310
[TBL] [Abstract][Full Text] [Related]
7. Histone methyltransferase SETDB1 promotes cells proliferation and migration by interacting withTiam1 in hepatocellular carcinoma.
Zhang Y; Huang J; Li Q; Chen K; Liang Y; Zhan Z; Ye F; Ni W; Chen L; Ding Y
BMC Cancer; 2018 May; 18(1):539. PubMed ID: 29739365
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
9. High SET Domain Bifurcated 1 (SETDB1) Expression Predicts Poor Prognosis in Breast Carcinoma.
Zhou Z; Wu B; Tang X; Yang W; Zou Q; Wang H
Med Sci Monit; 2020 Apr; 26():e922982. PubMed ID: 32305991
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Bioinformatics Analysis of Key Methyltransferases and Demethylases for Histone Lysines in Hepatocellular Carcinoma.
Zheng Y; Tang L; Chen G; Liu Z
Technol Cancer Res Treat; 2020; 19():1533033820983284. PubMed ID: 33355042
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of the epigenetic regulator SETDB1 in liver carcinogenesis-more than one way to skin a cat.
Longerich T
Chin Clin Oncol; 2016 Dec; 5(6):72. PubMed ID: 27164857
[TBL] [Abstract][Full Text] [Related]
12. The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma.
Xu L; Zhang M; Zheng X; Yi P; Lan C; Xu M
J Cancer Res Clin Oncol; 2017 Jan; 143(1):17-27. PubMed ID: 27614453
[TBL] [Abstract][Full Text] [Related]
13. High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma.
Li M; Luo RZ; Chen JW; Cao Y; Lu JB; He JH; Wu QL; Cai MY
J Transl Med; 2011 Jan; 9():5. PubMed ID: 21205329
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-621 Acts as a Tumor Radiosensitizer by Directly Targeting SETDB1 in Hepatocellular Carcinoma.
Shao Y; Song X; Jiang W; Chen Y; Ning Z; Gu W; Jiang J
Mol Ther; 2019 Feb; 27(2):355-364. PubMed ID: 30503969
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
16. High‑level SETD1B gene expression is associated with unfavorable prognosis in hepatocellular carcinoma.
Chen D; Li T; Wang C; Lei G; Wang R; Wang Z; Yu L; Yan J; Zhang P; Wang X; Zhang S; Yang P
Mol Med Rep; 2019 Mar; 19(3):1587-1594. PubMed ID: 30628696
[TBL] [Abstract][Full Text] [Related]
17. Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma.
Du M; Chen L; Zhao J; Tian F; Zeng H; Tan Y; Sun H; Zhou J; Ji Y
BMC Cancer; 2014 Jan; 14():38. PubMed ID: 24460749
[TBL] [Abstract][Full Text] [Related]
18. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of MMSET is correlation with poor prognosis in hepatocellular carcinoma.
Zhou P; Wu LL; Wu KM; Jiang W; Li JD; Zhou LD; Li XY; Chang S; Huang Y; Tan H; Zhang GW; He F; Wang ZM
Pathol Oncol Res; 2013 Apr; 19(2):303-9. PubMed ID: 23225158
[TBL] [Abstract][Full Text] [Related]
20. Histone-modifying genes as biomarkers in hepatocellular carcinoma.
Hung SY; Lin HH; Yeh KT; Chang JG
Int J Clin Exp Pathol; 2014; 7(5):2496-507. PubMed ID: 24966962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
